Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

227.72
Delayed Data
As of Jun 28
 +10.24 / +4.71%
Today’s Change
195.50
Today|||52-Week Range
340.34
-27.13%
Year-to-Date
Teva Inches Closer to Completion of Allergan Generics Deal
Jun 28 / TheStreet.com - Paid Partner Content
Cross Signs Flashing 'Watch and Wait'
Jun 23 / TheStreet.com - Paid Partner Content
Think Healthcare M&A Is Dead? Think Again.
Jun 28 / MotleyFool.com - Paid Partner Content
Jim Cramer's 'Mad Money' Recap: We Need More Mergers Right Now
Jun 22 / TheStreet.com - Paid Partner Content
20 stocks to buy after Brexit chaos
Jun 28 / CNNMoney.com
Impax (IPXL) Stock Declines on Deal to Buy Generic Products
Jun 22 / Zacks.com - Paid Partner Content
From The Street of Dreams
Jun 28 / TheStreet.com - Paid Partner Content
'Mad Money' Lightning Round: Be Patient on Alcoa
Jun 22 / TheStreet.com - Paid Partner Content
Brexit Bargain Buys: 14 More Stocks Picked by Morgan Stanley
Jun 28 / TheStreet.com - Paid Partner Content
Why Is Impax Labs Tumbling 11.7% Today
Jun 21 / MotleyFool.com - Paid Partner Content
Allergan Has Rolled Over Again
Jun 27 / TheStreet.com - Paid Partner Content
1 Stock to Invest in Big Pharma
Jun 19 / MotleyFool.com - Paid Partner Content
Teva's Cinqaero Gets Positive CHMP View, Decision in 2H16
Jun 27 / Zacks.com - Paid Partner Content
Paratek Reports Positive Phase III Data on Antibiotic Drug
Jun 17 / Zacks.com - Paid Partner Content
3 of Paul Singer's Top 5 Deals in 1st Quarter Involve Technology Stocks
Jun 26 / GuruFocus News - Paid Partner Content
3 High-Growth Stocks You Don't Need to Babysit
Jun 17 / MotleyFool.com - Paid Partner Content
Steve Mandel Exits Position in Williams Companies in 1st Quarter
Jun 24 / GuruFocus News - Paid Partner Content
Allergan Glaucoma Gel Stent Filing Accepted for FDA Review
Jun 17 / Zacks.com - Paid Partner Content
Brexit Sell-Off Hits 3 Big Pharma Bargain Stocks
Jun 24 / MotleyFool.com - Paid Partner Content
Stock Market News for June 16, 2016
Jun 16 / Zacks.com - Paid Partner Content
Allergan Is Primed for Increase After a Big Decline
Jun 24 / TheStreet.com - Paid Partner Content
M&A back on the table as 'big pharma' targets smaller rivals
Jun 02 / FT.com - Paid Partner Content
Allergan (AGN) Gets FDA Nod for Avycaz Label Expansion
Jun 24 / Zacks.com - Paid Partner Content
ConAgra climbs on Jana nominees update
May 31 / FT.com - Paid Partner Content
Better Buy: Valeant Pharmaceuticals International, Inc. vs. Allergan
Jun 23 / MotleyFool.com - Paid Partner Content
Carl Icahn buys 'big' stake in Allergan
May 31 / FT.com - Paid Partner Content